Growing Support for Metastatic Breast Cancer


Alisha Martin

AstraZeneca supports those who face a challenging disease on Metastatic Breast Cancer Awareness Day

A diagnosis of metastatic breast cancer (MBC) can bring with it feelings of uncertainty, fear and worry for women and their loved ones. While learning that breast cancer has moved from its origin to another location – most commonly the liver, lungs, bones or brain – can be overwhelming news, women diagnosed with metastatic breast cancer can find encouragement, support and comfort in each others’ stories and experiences.

That is why, in 2009, nine patients, in an effort to build awareness around the unique concerns and challenges of this particular type of cancer, traveled to Washington, D.C. and achieved the proclamation of October 13 as Metastatic Breast Cancer Awareness Day.

It is this symbolic day and the inspiring stories of approximately 159,000 women across the country who are living with this disease, that drive AstraZeneca to provide more resources and more medical research to support the changing needs of women with metastatic breast cancer.

For example, AstraZeneca recently launched the website My+Story. My+Story is tailored to the unique needs of metastatic breast cancer patients with a focus on mind, body and spirit, and offers a space for those who have been touched by this cancer to share their story. It also provides an opportunity for anyone to design and share a badge to show support for women with metastatic breast cancer. Each time you share a badge from this page to Facebook, Twitter, or Pinterest, AstraZeneca will make a donation to two MBC advocacy groups—Living Beyond Breast Cancer and Metastatic Breast Cancer Network.

On Metastatic Breast Cancer Awareness Day, please join AstraZeneca in supporting those with metastatic breast cancer by learning more about the disease, listening to their stories and creating your own badge to share.

Share a badge that represents you or a woman you care about who is living with metastatic breast cancer.